Electrocore LLC - Asset Resilience Ratio
Electrocore LLC (ECOR) has an Asset Resilience Ratio of 23.79% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ECOR total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Electrocore LLC's Asset Resilience Ratio has changed over time. See ECOR net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Electrocore LLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Electrocore LLC market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $5.09 Million | 23.79% |
| Total Liquid Assets | $5.09 Million | 23.79% |
Asset Resilience Insights
- Good Liquidity Position: Electrocore LLC maintains a healthy 23.79% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Electrocore LLC Industry Peers by Asset Resilience Ratio
Compare Electrocore LLC's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 3.37% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS |
Medical Devices | 54.67% |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO |
Medical Devices | 30.97% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Acarix A/S
ST:ACARIX |
Medical Devices | 37.81% |
Annual Asset Resilience Ratio for Electrocore LLC (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Electrocore LLC.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 41.61% | $8.52 Million | $20.47 Million | -- |
| 2023-12-31 | 0.00% | $0.00 | $16.10 Million | -- |
| 2021-12-31 | 0.00% | $0.00 | $42.83 Million | -- |
| 2020-12-31 | 58.34% | $18.39 Million | $31.52 Million | +28.74pp |
| 2019-12-31 | 29.60% | $10.50 Million | $35.46 Million | -53.34pp |
| 2018-12-31 | 82.94% | $60.96 Million | $73.50 Million | +21.89pp |
| 2017-12-31 | 61.05% | $23.95 Million | $39.23 Million | -- |
About Electrocore LLC
electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster … Read more